Additionally, in glioblastoma multiforme (GBM), epidermal growth factor receptor (EGFR) and rictor-mediated pathways have been shown to play a key role in chemoresistance (increased viability) [26]. The gene discussed is RICTOR; the disease is glioblastoma.